These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 7745730)

  • 1. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
    Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
    J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    Freed EO; Martin MA
    J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
    Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
    J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
    Murakami T; Freed EO
    J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
    Freed EO; Martin MA
    J Virol; 1995 Mar; 69(3):1984-9. PubMed ID: 7853546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
    J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
    Murakami T; Ablan S; Freed EO; Tanaka Y
    J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
    Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
    J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of matrix in HIV-1 envelope glycoprotein incorporation.
    Tedbury PR; Freed EO
    Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
    Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
    J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.
    Lodge R; Göttlinger H; Gabuzda D; Cohen EA; Lemay G
    J Virol; 1994 Aug; 68(8):4857-61. PubMed ID: 8035484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
    Eastep GN; Ghanam RH; Green TJ; Saad JS
    J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
    Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
    J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.
    González SA; Burny A; Affranchino JL
    J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
    J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.